CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 31)
13 Mar 2023 While the collapse in SVB will unlikely trigger another financial crisis, it...
CROSBY Research – Concord New Energy (182 HK/BUY): Bodes well into the grid parity era
08 Mar 2023 CNE’s FY22 revenue was up by 22.0% YoY to Rmb2,679m, mainly due...
CROSBY Research – Pentamaster International (1665 HK/BUY): Order book surged in 4Q22 driven by strong automotive and medical devices demand
02 Mar 2023 Pentamaster’s 4Q22 revenue increased 20.6% YoY from MYR122.4m in 4Q21 to MYR147.7m...
CROSBY Research – SIIC Environment (807 HK): Further expansion in GBA & YREB regions
01 Mar 2023 SIIC reported its FY22 result with an increase in revenue by 14.3%...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 30)
27 Feb 2023 Christopher Hui, secretary for HKSAR financial services and the treasury, said on...
CROSBY Research – Vincent Medical (1612 HK/Neutral): Weak respiratory sales and inventory pile-up dented bottom line
14 Feb 2023 Vincent Medical (VM) issued a profit warning citing that its FY22 reported...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 29)
13 Feb 2023 The Chinese medical device market is one of opportunities. It is both...
CROSBY Research – Nagacorp (3918 HK): Recovering from the pandemic
10 Feb 2023 Naga’s FY22 revenue was up by 104% YoY to US$461m, mainly driven...
CROSBY Research – Vinda International (3331 HK): The worst should be over
31 Jan 2023 Vinda announced FY22 results, with revenue increased by 8.1% YoY to HK$19.4bn...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 28)
30 Jan 2023 A total of 484,505 tourists entered Macau during CNY this year, which...
CROSBY Research – Xtep International (1368 HK/BUY): The worst has passed, a year of recovery in 2023
19 Jan 2023 Xtep reported its 4Q22 operational data with retail sell-through (including both online...
CROSBY Research – China Everbright Greentech (1257 HK/BUY): FY22 results preview
13 Jan 2023 CEG’s 1H22 revenue edged down by 2% YoY to HK$4,220m, and 1H22NP...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 27)
09 Jan 2023 HK/China border fully reopened on 8th Jan 2023. Sun Hung Kai Properties...
CROSBY Research – Channel Micron (2115 HK/BUY): Key beneficiary of China’s massive semiconductor factory buildout and international enterprises investment trends in Southeast AsiaCROSBY Research
06 Jan 2023 Channel Micron is a leading cleanroom system provider based in China and...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 26) – Feature Article: Renewable Energy – Demand for distributed wind power on the rise
05 Dec 2022 Decentralized wind power is becoming a new growth point in the wind...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 25)
22 Nov 2022 Hong Kong unemployment rate dropped slightly from 3.9% (May to Jul) to...
CROSBY Research – Man Wah (1999 HK): Higher GPM on lower RM costs
16 Nov 2022 Man Wah reported its Sept ended 1HFY23 results with top line decreased...
CROSBY Research – Microport NeuroTech (2172 HK): A premium Chinese neuro-interventional medical device play
15 Nov 2022 Newly debuted on HKEX in July this year, MicroPort NeuroTech (MNT) is...
CROSBY Research – Channel Micron (2115 HK): Key beneficiary of China’s massive semiconductor factory buildout
09 Nov 2022 Channel Micron is a leading cleanroom system provider based in China and...
CROSBY Research – Precision Tsugami (China) (1651 HK/BUY): Tough 1H23 amid pandemic headwinds
09 Nov 2022 Following a spectacular FY22, Precision Tsugami (China) (PTC) encountered headwinds in 1H23...